Quest Seeks to Stop Sale of Correlogic's Assets, Claims Rights to OvaCheck IP | GenomeWeb

This story originally ran on April 12 and has been updated to include comments from a Correlogic official.

By Adam Bonislawski

Quest Diagnostics last week filed an objection seeking to stop Correlogic Systems' auction of its assets as part of its ongoing bankruptcy proceedings.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.